Ibritumomab Injection

55 interactions 99 cited references
Also sold as: Zevalin®
About Ibritumomab Injection

Ibritumomab injection is used with rituximab (Rituxan) to treat certain types of non-Hodgkin's lymphoma (NHL; cancer that begins in the cells of the immune system) that has not improved or that has worsened after treatment with other medications. It is also used to treat certain types of NHL in people who have improved… Read the full Ibritumomab Injection drug information page →

Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Moderate

Ibritumomab Injection Abciximab An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Acenocoumarol An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Anagrelide Agrylin An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Anisindione An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Ardeparin An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Aspirin Acuprin® An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Bemiparin An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Bivalirudin Angiomax An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Certoparin An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Cilostazol Pletal® An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Clopidogrel Plavix An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Dalteparin Fragmin An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Danaparoid An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Defibrotide An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Dermatan Sulfate An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Desirudin Iprivask An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Dicumarol An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Dipyridamole Permole® An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Enoxaparin Lovenox An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Epoprostenol Flolan An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Eptifibatide An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Fondaparinux Arixtra An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Heparin An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Iloprost Aurlumyn An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Lamifiban An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Lepirudin An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Nadroparin An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Parnaparin An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Phenindione An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Phenprocoumon An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Reviparin An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Sibrafiban An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Sulfinpyrazone An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Sulodexide An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Ticlopidine Ticlid® An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Tinzaparin An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Tirofiban An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Treprostinil Orenitram An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Warfarin Coumadin An increased risk of bleeding and hemorrhage Details Ibritumomab Injection Xemilofiban An increased risk of bleeding and hemorrhage Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.